| Combinatorial therapy in tumor microenvironment: where do we stand? S Kumari, D Advani, S Sharma, RK Ambasta, P Kumar Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1876 (2), 188585, 2021 | 80 | 2021 |
| Unboxing the molecular modalities of mutagens in cancer S Kumari, S Sharma, D Advani, A Khosla, P Kumar, RK Ambasta Environmental Science and Pollution Research, 1-49, 2021 | 40 | 2021 |
| New era of artificial intelligence and machine learning-based detection, diagnosis, and therapeutics in Parkinson’s disease R Gupta, S Kumari, A Senapati, RK Ambasta, P Kumar Ageing research reviews, 102013, 2023 | 38 | 2023 |
| Computationally designed antibody–drug conjugates self-assembled via affinity ligands N Gupta, A Ansari, GV Dhoke, M Chilamari, J Sivaccumar, S Kumari, ... Nature biomedical engineering 3 (11), 917-929, 2019 | 23 | 2019 |
| Activation of epithelial-mesenchymal transition and altered β-catenin signaling in a novel Indian colorectal carcinoma cell line S Mylavarapu, H Kumar, S Kumari, LS Sravanthi, M Jain, A Basu, ... Frontiers in Oncology 9, 54, 2019 | 17 | 2019 |
| Precision oncology, signaling, and anticancer agents in cancer therapeutics D Advani, S Sharma, S Kumari, RK Ambasta, P Kumar Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2022 | 16 | 2022 |
| A safe and efficacious Pt (ii) anticancer prodrug: design, synthesis, in vitro efficacy, the role of carrier ligands and in vivo tumour growth inhibition PK Dutta, R Sharma, S Kumari, RD Dubey, S Sarkar, J Paulraj, ... Chemical Communications 55 (12), 1718-1721, 2019 | 11 | 2019 |
| Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy S Kumari, R Gupta, RK Ambasta, P Kumar Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1878 (4), 188913, 2023 | 10 | 2023 |
| Unwinding the modalities of necrosome activation and necroptosis machinery in neurological diseases R Gupta, S Kumari, R Tripathi, RK Ambasta, P Kumar Ageing Research Reviews 86, 101855, 2023 | 8 | 2023 |
| Design and computational analysis of an MMP9 inhibitor in hypoxia-induced glioblastoma multiforme S Kumari, P Kumar ACS omega 8 (11), 10565-10590, 2023 | 5 | 2023 |
| Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme S Kumari, R Gupta, RK Ambasta, P Kumar Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1878 (6), 188999, 2023 | 1 | 2023 |
| Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment S Kumari, P Kumar Frontiers in Cell and Developmental Biology 11, 2023 | 1 | 2023 |
| Phenalenyl based platinum anticancer compounds with superior efficacy: design, synthesis, characterization, and interaction with nuclear DNA P Dutta, S Kumari, J Paulraj, R Sharma, G Vijaykumar, HS Das, ... New Journal of Chemistry 45 (23), 10524-10533, 2021 | 1 | 2021 |
| IO-125: A novel supramolecular platinum chemotherapy for triple negative breast cancer. A Sengupta, S Mylavarapu, S Kumari, S Hossain, N Gupta, A Sarkar, ... Journal of Clinical Oncology 33 (28_suppl), 153-153, 2015 | 1 | 2015 |
Pravir KumarDean (International Affairs), Professor (Biotechnology), Delhi Technological University在 dtu.ac.in 的电子邮件经过验证
